Navigation Links
Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
Date:5/16/2008

openia.

About Nektar

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development technology platforms. Nektar PEGylation and pulmonary technology, expertise, manufacturing capabilities have enabled eight approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.

This press release contains forward-looking statements regarding the potential of NKTR-102 and Nektar's PEGylation technology platform. These forward-looking statements involve important risks and uncertainties, including but not limited to: (i) clinical trials for NKTR-102 are long, expensive and uncertain processes; (ii) because NKTR-102 is in the early phases of clinical development, the risk of failure is high and can occur at any stage of development regardless of promising data from one or more prior preclinical or clinical studies, (iii) the timing or success of the commencement or end of clinical trials may be delayed or unsuccessful due to slower than anticipated patient enrollment, drug manufacturing challenges, changing standards of care, clinical trial design, and/or clinical outcomes; (iv) Nektar may fail to obtain regulatory approval of NKTR-102; (v) potential competition from existing approved products (branded or generic) or product candidates under development by other companies could negatively impact the commercial potential of NKTR-102 due to such common industry competitive factors as efficacy and safety profiles, pricing, and reimbursement by third party payers; and (vi) Nektar's patent applications for NKTR-102 may fail to issue; patents that have issued may not be enforceable; or unanticipat
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
2. DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux
3. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
4. Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS)
5. Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
6. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
9. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
10. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
11. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 20, 2014 Oxis International, Inc. ... , the election of Anthony J. Cataldo as ... Effective November 19, 2014, Ken Eaton ... the Board of Directors of Oxis International, Inc. to pursue ... has been named Chief Executive Officer of Oxis International, Inc. ...
(Date:11/21/2014)... 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... offering of $80,000,000 aggregate principal amount of 5.25% Convertible ... private offering within the United States ... buyers pursuant to Rule 144A under the Securities Act ... also granted the initial purchasers an option to purchase ...
(Date:11/18/2014)... ANGELES , Nov. 18, 2014  Sanguine ... development, patient engagement and study recruitment – will ... called Sangre, to help Pfizer Inc. find and ... (CIP) and their family members to participate in ... potentially identify DNA mutations and hopefully aid in ...
Breaking Medicine Technology:OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3Sanguine's Mobile Application to Assist Recruitment for Pfizer Inc. Chronic Pain Research 2
... , KNOXVILLE, Tenn., Dec. 2 ... nation,s largest provider of hospital-based clinical outsourcing, announced it ... two groups in South Carolina and Illinois. , An ... S.C., will allow TeamHealth Teleradiology to provide services for ...
... , WALTHAM, Mass. and NEW YORK, Dec. ... and NYU Langone Medical Center announced findings from a study ... osteoarthritis have been published this week in the "Online First" ... at http://ard.bmj.com/cgi/rapidpdf/ard.2009.113043v1.pdf . Results from ...
Cached Medicine Technology:TeamHealth Teleradiology Announces New Contracts in South Carolina and Illinois 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4
(Date:11/22/2014)... New York (PRWEB) November 22, 2014 ... on behalf of patients who allegedly developed Type 2 ... in the federal multidistrict litigation now underway in U.S. ... reports. According to court documents, the litigation will convene ... a.m. The Court has directed Lead Counsel for Plaintiffs ...
(Date:11/22/2014)... UWDress.com is gratified to introduce its new collection of ... company has also offered an attracting discount on these ... of wedding dresses, UWDress.com is good at manufacturing all ... gowns are provided over 20 colors, which have diverse ... famous for high quality. Therefore, its sales increased quickly ...
(Date:11/22/2014)... November 22, 2014 Sandbridge Capital, ... investments in the consumer brand sector, acquired a ... will be used to help fund BackJoy’s global ... rollout, particularly its proprietary apparel and footwear lines. ... BackJoy’s Board of Directors. , BackJoy is a ...
(Date:11/22/2014)... “Greenfield Naturals” was featured on NewsWatch as part ... the latest and coolest technology products available to consumers. ... conducted the product review and shared with viewers how ... , From pollution to hazardous substances in water, harmful ... to remove these chemicals, especially in water. , A ...
(Date:11/22/2014)... 2014 (HealthDay News) -- A clinical trial of hydroxyurea ... halted a year early because the results show it ... disease and reduce the risk of stroke. The ... medical centers in the United States and Canada, was ... and Blood Institute (NHLBI). Researchers compared monthly blood ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 2Health News:Sandbridge Capital Acquires a Minority Stake in BackJoy 3Health News:An Easy Home Solution to Get Better Tasting Water was Featured on NewsWatch Television on October 30, 2014 2Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2
... loss, expert says , MONDAY, March 22 (HealthDay News) ... people with mild cognitive impairment, the stage before Alzheimer,s ... that we need to pay attention to this time ... starting to have problems forgetting things," study author Robert ...
... Infertile men ... the average man according to a new study published in the journal, Cancer. , ... San Francisco, Calif. (Vocus) March 22, ... prostate cancer than fertile men according to a new study published in the journal, Cancer., ...
... 22 The Single Party finally bought enough votes to get the Senate-passed healthcare reform through the House, but its victory celebrations ... since "healthcare reform" was first promoted in 1943. , ... , ... ...
... Blue Cross and Blue Shield of Georgia ... bring a regional clinic to Georgia from today, ... Clayton County , Henry County and Spalding County ... based on their financial and vision needs to receive free vision ...
... Across the Country to Make Smart Choices , ... , , ... ... WASHINGTON , March 22 The ...
... were 2.6 times more likely to get more dangerous disease ... risk that a man will develop the aggressive, potentially fatal ... my knowledge, this is the first study to identify a ... Thomas J. Walsh, an assistant professor of urology at the ...
Cached Medicine News:Health News:Brain Function May Drop Quickly Before Alzheimer's 2Health News:Male Infertility Significantly Increases Risk of Prostate Cancer 2Health News:Physicians Urged to Declare Independence from Government, Other Third Parties 2Health News:Physicians Urged to Declare Independence from Government, Other Third Parties 3Health News:Hundreds of Georgia School Children to Receive Free Eye Exams and Glasses 2Health News:Hundreds of Georgia School Children to Receive Free Eye Exams and Glasses 3Health News:Hundreds of Georgia School Children to Receive Free Eye Exams and Glasses 4Health News:Hundreds of Georgia School Children to Receive Free Eye Exams and Glasses 5Health News:National Restaurant Association Says Nutrition Information Provision Is Win for Consumers and Restaurants 2Health News:National Restaurant Association Says Nutrition Information Provision Is Win for Consumers and Restaurants 3Health News:Infertility Raises Risk of More Aggressive Prostate Cancer 2
... Innovators in Anesthesia and Respiratory Products, ... medical devices for Anesthesia and Respiratory professionals. ... products that enhance the clinician's ability to ... attention to the bottom line. , ...
... and Respiratory Products, ,Westmed designs, manufacturers ... Anesthesia and Respiratory professionals. Our mission is ... the clinician's ability to deliver quality medical ... bottom line. , ,Our web site ...
... the new PRONEB® ULTRA compressor. This high ... while delivering more medication to the patient's ... PLUS® or PARI LC STAR® Reusable Nebulizer, ... for inhalation and retention into the lungs. ...
... use with metered dose inhalers., ,ACE ... from MDI canisters. Its versatile design allows ... circuit, in conjunction with an endotracheal airway ... inhalation. ACE may also be used in ...
Medicine Products: